nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C19—Esomeprazole—Barrett's esophagus	0.279	0.359	CbGbCtD
Nilutamide—CYP2C8—Omeprazole—Barrett's esophagus	0.196	0.253	CbGbCtD
Nilutamide—CYP2C19—Omeprazole—Barrett's esophagus	0.164	0.212	CbGbCtD
Nilutamide—CYP2C9—Omeprazole—Barrett's esophagus	0.137	0.176	CbGbCtD
Nilutamide—Creatinine increased—Omeprazole—Barrett's esophagus	0.00358	0.0166	CcSEcCtD
Nilutamide—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00358	0.0166	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.0034	0.0158	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.0034	0.0158	CcSEcCtD
Nilutamide—Melaena—Omeprazole—Barrett's esophagus	0.00333	0.0155	CcSEcCtD
Nilutamide—Melaena—Esomeprazole—Barrett's esophagus	0.00333	0.0155	CcSEcCtD
Nilutamide—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00305	0.0142	CcSEcCtD
Nilutamide—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00305	0.0142	CcSEcCtD
Nilutamide—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00297	0.0138	CcSEcCtD
Nilutamide—Abnormal vision—Omeprazole—Barrett's esophagus	0.00297	0.0138	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00284	0.0132	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00284	0.0132	CcSEcCtD
Nilutamide—Hot flush—Esomeprazole—Barrett's esophagus	0.00264	0.0123	CcSEcCtD
Nilutamide—Hot flush—Omeprazole—Barrett's esophagus	0.00264	0.0123	CcSEcCtD
Nilutamide—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00262	0.0122	CcSEcCtD
Nilutamide—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00262	0.0122	CcSEcCtD
Nilutamide—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00261	0.0121	CcSEcCtD
Nilutamide—Visual disturbance—Omeprazole—Barrett's esophagus	0.00261	0.0121	CcSEcCtD
Nilutamide—Arthritis—Esomeprazole—Barrett's esophagus	0.00254	0.0118	CcSEcCtD
Nilutamide—Arthritis—Omeprazole—Barrett's esophagus	0.00254	0.0118	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00247	0.0115	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00247	0.0115	CcSEcCtD
Nilutamide—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00232	0.0108	CcSEcCtD
Nilutamide—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00232	0.0108	CcSEcCtD
Nilutamide—Dry skin—Omeprazole—Barrett's esophagus	0.00227	0.0105	CcSEcCtD
Nilutamide—Dry skin—Esomeprazole—Barrett's esophagus	0.00227	0.0105	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00223	0.0103	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00223	0.0103	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00218	0.0101	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00218	0.0101	CcSEcCtD
Nilutamide—Influenza—Omeprazole—Barrett's esophagus	0.00214	0.00993	CcSEcCtD
Nilutamide—Influenza—Esomeprazole—Barrett's esophagus	0.00214	0.00993	CcSEcCtD
Nilutamide—Angina pectoris—Omeprazole—Barrett's esophagus	0.00208	0.00967	CcSEcCtD
Nilutamide—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00208	0.00967	CcSEcCtD
Nilutamide—POR—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00208	0.228	CbGpPWpGaD
Nilutamide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00199	0.00923	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00199	0.00923	CcSEcCtD
Nilutamide—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00197	0.00914	CcSEcCtD
Nilutamide—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00197	0.00914	CcSEcCtD
Nilutamide—Weight decreased—Omeprazole—Barrett's esophagus	0.00193	0.00898	CcSEcCtD
Nilutamide—Weight decreased—Esomeprazole—Barrett's esophagus	0.00193	0.00898	CcSEcCtD
Nilutamide—Depression—Esomeprazole—Barrett's esophagus	0.0019	0.00883	CcSEcCtD
Nilutamide—Depression—Omeprazole—Barrett's esophagus	0.0019	0.00883	CcSEcCtD
Nilutamide—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00185	0.0086	CcSEcCtD
Nilutamide—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00185	0.0086	CcSEcCtD
Nilutamide—Haematuria—Omeprazole—Barrett's esophagus	0.00182	0.00844	CcSEcCtD
Nilutamide—Haematuria—Esomeprazole—Barrett's esophagus	0.00182	0.00844	CcSEcCtD
Nilutamide—Rhinitis—Omeprazole—Barrett's esophagus	0.00171	0.00797	CcSEcCtD
Nilutamide—Rhinitis—Esomeprazole—Barrett's esophagus	0.00171	0.00797	CcSEcCtD
Nilutamide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.0017	0.00791	CcSEcCtD
Nilutamide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.0017	0.00791	CcSEcCtD
Nilutamide—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00169	0.00785	CcSEcCtD
Nilutamide—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00169	0.00785	CcSEcCtD
Nilutamide—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00168	0.00783	CcSEcCtD
Nilutamide—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00168	0.00783	CcSEcCtD
Nilutamide—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00168	0.00779	CcSEcCtD
Nilutamide—Urethral disorder—Omeprazole—Barrett's esophagus	0.00168	0.00779	CcSEcCtD
Nilutamide—Visual impairment—Esomeprazole—Barrett's esophagus	0.00165	0.00766	CcSEcCtD
Nilutamide—Visual impairment—Omeprazole—Barrett's esophagus	0.00165	0.00766	CcSEcCtD
Nilutamide—Alopecia—Omeprazole—Barrett's esophagus	0.00151	0.00702	CcSEcCtD
Nilutamide—Alopecia—Esomeprazole—Barrett's esophagus	0.00151	0.00702	CcSEcCtD
Nilutamide—Tension—Esomeprazole—Barrett's esophagus	0.00146	0.00679	CcSEcCtD
Nilutamide—Tension—Omeprazole—Barrett's esophagus	0.00146	0.00679	CcSEcCtD
Nilutamide—Nervousness—Omeprazole—Barrett's esophagus	0.00145	0.00672	CcSEcCtD
Nilutamide—Nervousness—Esomeprazole—Barrett's esophagus	0.00145	0.00672	CcSEcCtD
Nilutamide—Back pain—Omeprazole—Barrett's esophagus	0.00144	0.00669	CcSEcCtD
Nilutamide—Back pain—Esomeprazole—Barrett's esophagus	0.00144	0.00669	CcSEcCtD
Nilutamide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00138	0.00642	CcSEcCtD
Nilutamide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00138	0.00642	CcSEcCtD
Nilutamide—Anaemia—Esomeprazole—Barrett's esophagus	0.00138	0.00639	CcSEcCtD
Nilutamide—Anaemia—Omeprazole—Barrett's esophagus	0.00138	0.00639	CcSEcCtD
Nilutamide—Malaise—Esomeprazole—Barrett's esophagus	0.00134	0.00624	CcSEcCtD
Nilutamide—Malaise—Omeprazole—Barrett's esophagus	0.00134	0.00624	CcSEcCtD
Nilutamide—Leukopenia—Omeprazole—Barrett's esophagus	0.00133	0.00619	CcSEcCtD
Nilutamide—Leukopenia—Esomeprazole—Barrett's esophagus	0.00133	0.00619	CcSEcCtD
Nilutamide—Cough—Esomeprazole—Barrett's esophagus	0.0013	0.00604	CcSEcCtD
Nilutamide—Cough—Omeprazole—Barrett's esophagus	0.0013	0.00604	CcSEcCtD
Nilutamide—Hypertension—Omeprazole—Barrett's esophagus	0.00129	0.00597	CcSEcCtD
Nilutamide—Hypertension—Esomeprazole—Barrett's esophagus	0.00129	0.00597	CcSEcCtD
Nilutamide—Chest pain—Esomeprazole—Barrett's esophagus	0.00127	0.00589	CcSEcCtD
Nilutamide—Chest pain—Omeprazole—Barrett's esophagus	0.00127	0.00589	CcSEcCtD
Nilutamide—Discomfort—Esomeprazole—Barrett's esophagus	0.00125	0.00582	CcSEcCtD
Nilutamide—Discomfort—Omeprazole—Barrett's esophagus	0.00125	0.00582	CcSEcCtD
Nilutamide—Dry mouth—Omeprazole—Barrett's esophagus	0.00124	0.00576	CcSEcCtD
Nilutamide—Dry mouth—Esomeprazole—Barrett's esophagus	0.00124	0.00576	CcSEcCtD
Nilutamide—Shock—Esomeprazole—Barrett's esophagus	0.0012	0.00555	CcSEcCtD
Nilutamide—Shock—Omeprazole—Barrett's esophagus	0.0012	0.00555	CcSEcCtD
Nilutamide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00117	0.00546	CcSEcCtD
Nilutamide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00117	0.00546	CcSEcCtD
Nilutamide—Anorexia—Esomeprazole—Barrett's esophagus	0.00116	0.00538	CcSEcCtD
Nilutamide—Anorexia—Omeprazole—Barrett's esophagus	0.00116	0.00538	CcSEcCtD
Nilutamide—Insomnia—Esomeprazole—Barrett's esophagus	0.0011	0.00511	CcSEcCtD
Nilutamide—Insomnia—Omeprazole—Barrett's esophagus	0.0011	0.00511	CcSEcCtD
Nilutamide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00109	0.00507	CcSEcCtD
Nilutamide—Paraesthesia—Omeprazole—Barrett's esophagus	0.00109	0.00507	CcSEcCtD
Nilutamide—Dyspnoea—Omeprazole—Barrett's esophagus	0.00108	0.00503	CcSEcCtD
Nilutamide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00108	0.00503	CcSEcCtD
Nilutamide—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00107	0.00497	CcSEcCtD
Nilutamide—Dyspepsia—Omeprazole—Barrett's esophagus	0.00107	0.00497	CcSEcCtD
Nilutamide—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00106	0.00491	CcSEcCtD
Nilutamide—Decreased appetite—Omeprazole—Barrett's esophagus	0.00106	0.00491	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00105	0.00487	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00105	0.00487	CcSEcCtD
Nilutamide—Constipation—Esomeprazole—Barrett's esophagus	0.00104	0.00483	CcSEcCtD
Nilutamide—Pain—Omeprazole—Barrett's esophagus	0.00104	0.00483	CcSEcCtD
Nilutamide—Constipation—Omeprazole—Barrett's esophagus	0.00104	0.00483	CcSEcCtD
Nilutamide—Pain—Esomeprazole—Barrett's esophagus	0.00104	0.00483	CcSEcCtD
Nilutamide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.001	0.00465	CcSEcCtD
Nilutamide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.001	0.00465	CcSEcCtD
Nilutamide—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000993	0.00462	CcSEcCtD
Nilutamide—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000993	0.00462	CcSEcCtD
Nilutamide—Body temperature increased—Omeprazole—Barrett's esophagus	0.00096	0.00446	CcSEcCtD
Nilutamide—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00096	0.00446	CcSEcCtD
Nilutamide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00096	0.00446	CcSEcCtD
Nilutamide—Abdominal pain—Omeprazole—Barrett's esophagus	0.00096	0.00446	CcSEcCtD
Nilutamide—Asthenia—Esomeprazole—Barrett's esophagus	0.000872	0.00405	CcSEcCtD
Nilutamide—Asthenia—Omeprazole—Barrett's esophagus	0.000872	0.00405	CcSEcCtD
Nilutamide—Pruritus—Omeprazole—Barrett's esophagus	0.000859	0.00399	CcSEcCtD
Nilutamide—Pruritus—Esomeprazole—Barrett's esophagus	0.000859	0.00399	CcSEcCtD
Nilutamide—Diarrhoea—Omeprazole—Barrett's esophagus	0.000831	0.00386	CcSEcCtD
Nilutamide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000831	0.00386	CcSEcCtD
Nilutamide—Dizziness—Omeprazole—Barrett's esophagus	0.000803	0.00373	CcSEcCtD
Nilutamide—Dizziness—Esomeprazole—Barrett's esophagus	0.000803	0.00373	CcSEcCtD
Nilutamide—Vomiting—Esomeprazole—Barrett's esophagus	0.000772	0.00359	CcSEcCtD
Nilutamide—Vomiting—Omeprazole—Barrett's esophagus	0.000772	0.00359	CcSEcCtD
Nilutamide—Rash—Omeprazole—Barrett's esophagus	0.000766	0.00356	CcSEcCtD
Nilutamide—Rash—Esomeprazole—Barrett's esophagus	0.000766	0.00356	CcSEcCtD
Nilutamide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000765	0.00356	CcSEcCtD
Nilutamide—Dermatitis—Omeprazole—Barrett's esophagus	0.000765	0.00356	CcSEcCtD
Nilutamide—Headache—Omeprazole—Barrett's esophagus	0.000761	0.00354	CcSEcCtD
Nilutamide—Headache—Esomeprazole—Barrett's esophagus	0.000761	0.00354	CcSEcCtD
Nilutamide—Nausea—Esomeprazole—Barrett's esophagus	0.000722	0.00335	CcSEcCtD
Nilutamide—Nausea—Omeprazole—Barrett's esophagus	0.000722	0.00335	CcSEcCtD
Nilutamide—AR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.000683	0.075	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00054	0.0593	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000339	0.0372	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000302	0.0332	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000284	0.0312	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000284	0.0312	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000276	0.0302	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—PPARG—Barrett's esophagus	0.000225	0.0247	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000222	0.0243	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000219	0.024	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000198	0.0217	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000195	0.0214	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000181	0.0198	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00018	0.0197	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000178	0.0196	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000178	0.0195	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000161	0.0176	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000146	0.0161	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000142	0.0156	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—Barrett's esophagus	0.00013	0.0142	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.000128	0.0141	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000104	0.0114	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	9.55e-05	0.0105	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	9.46e-05	0.0104	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.42e-05	0.0103	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.36e-05	0.0103	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	9.33e-05	0.0102	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	9.22e-05	0.0101	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	8.53e-05	0.00936	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.41e-05	0.00923	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	7.78e-05	0.00853	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.67e-05	0.00841	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	6.65e-05	0.00729	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.4e-05	0.00702	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	5.93e-05	0.00651	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	5.54e-05	0.00608	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	5.41e-05	0.00593	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.86e-05	0.00533	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.84e-05	0.00531	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR1I2—Barrett's esophagus	4.49e-05	0.00493	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.32e-05	0.00474	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	3.94e-05	0.00432	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	3.49e-05	0.00383	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARG—Barrett's esophagus	3.07e-05	0.00337	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.89e-05	0.00317	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGES—Barrett's esophagus	2.16e-05	0.00237	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGES—Barrett's esophagus	1.92e-05	0.00211	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGES—Barrett's esophagus	1.75e-05	0.00193	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	1.63e-05	0.00179	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—Barrett's esophagus	1.48e-05	0.00162	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	1.46e-05	0.0016	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	1.33e-05	0.00146	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.21e-05	0.00132	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.18e-05	0.00129	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.08e-05	0.00118	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.05e-05	0.00115	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	9.83e-06	0.00108	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	9.59e-06	0.00105	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	9.5e-06	0.00104	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8.48e-06	0.00093	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.73e-06	0.000848	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—Barrett's esophagus	5.38e-06	0.00059	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—Barrett's esophagus	4.8e-06	0.000527	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—Barrett's esophagus	4.38e-06	0.00048	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	4.23e-06	0.000464	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	3.78e-06	0.000414	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	3.44e-06	0.000378	CbGpPWpGaD
